NASDAQ: IBRX
Immunitybio Inc Stock Ownership - Who owns Immunitybio?

Insider buying vs selling

Have Immunitybio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Barry J. SimonDirector2026-10-0525,000$10.75
$268.75kSell
Cheryl CohenDirector2026-10-0255,979$2.98
$166.82kBuy
Cheryl CohenDirector2026-10-0281,056$10.50
$851.09kSell
Cheryl CohenDirector2026-07-0255,979$2.98
$166.82kBuy
Cheryl CohenDirector2026-07-02131,210$9.50
$1.25MSell
Christobel SeleckyDirector2026-07-0135,064$2.98
$104.49kBuy
Christobel SeleckyDirector2026-07-01159,478$9.02
$1.44MSell
Christobel SeleckyDirector2026-07-01124,414$2.99
$372.00kBuy
Christobel SeleckyDirector2026-06-301,000$9.00
$9.00kSell
Christobel SeleckyDirector2026-06-30700$2.98
$2.09kBuy

1 of 4

IBRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IBRX insiders and whales buy or sell their stock.

IBRX Shareholders

What type of owners hold Immunitybio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Patrick Soonshiong6.61%70,341,055$423.45MInsider
Barry J. Simon0.26%2,798,931$16.85MInsider
Henry Ji0.07%776,535$4.67MInsider
Richard Adcock0.05%562,274$3.38MInsider
Richard Kusserow0.04%394,053$2.37MInsider
David C. Sachs0.03%300,143$1.81MInsider
Michael D. Blaszyk0.02%265,582$1.60MInsider
John C. Thomas0.02%216,363$1.30MInsider
John T. Potts Jr.0.01%159,253$958.70kInsider
Regan J. Lauer0.01%115,875$697.57kInsider

1 of 3

IBRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IBRX0.01%7.18%Net BuyingNet Selling
BLTE0.00%1.18%Net SellingNet Selling
ARWR0.05%9.72%Net SellingNet Selling
KOD0.02%65.72%Net BuyingNet Buying
ABVX0.03%0.00%

Immunitybio Stock Ownership FAQ

Who owns Immunitybio?

Immunitybio (NASDAQ: IBRX) is owned by 0.01% institutional shareholders, 7.18% Immunitybio insiders, and 92.80% retail investors. Patrick Soonshiong is the largest individual Immunitybio shareholder, owning 70.34M shares representing 6.61% of the company. Patrick Soonshiong's Immunitybio shares are currently valued at $420.64M.

If you're new to stock investing, here's how to buy Immunitybio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.